Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar;23(3):189.
doi: 10.3892/etm.2022.11112. Epub 2022 Jan 4.

From chronic pruritus to neuroendocrine tumor: A case report

Affiliations
Case Reports

From chronic pruritus to neuroendocrine tumor: A case report

Alexandr Ceasovschih et al. Exp Ther Med. 2022 Mar.

Abstract

Chronic pruritus is a major and distressing symptom of many diseases of dermatological, neurological, psychogenic or systemic origin. This chronic itch could be a presenting sign of malignancy; therefore, paraneoplastic pruritus has also been associated with neuroendocrine tumors (NETs). This article focuses on a patient presenting with chronic pruritus for the past 12 months and who received numerous treatment schemes with very poor clinical improvement, that presented in the hospital for worsening of the chronic pruritus associated with skin rash and significant weight loss (approximately 6 kg over a 2-month period). The laboratory tests showed iron deficiency anemia, eosinophilia and negative tumor markers. In order to investigate the hypoanabolic and anemic syndromes, upper gastrointestinal endoscopy and colonoscopy, which showed no lesions or tumors, were employed. Skin biopsy was performed and antihistaminic and local steroid treatment was initiated. The patient's status worsened within a week and the patient was started on systemic steroid treatment with poor results. Computer tomography was performed to identify any tumor(s) located either in the pelvis or abdomen. A lesion was found in the terminal ileum, identified as a hypervascularized associating bulky lymphadenopathy. The patient was transferred to the surgical ward where right hemicolectomy with manual ileotransverse anastomosis L-L was performed. The histopathological result confirmed NET G2. The patient clinically improved, the skin lesions resolved and the itchiness disappeared. The general status improved significantly. NET G2 diagnosing was possible due to the atypic paraneoplastic sign: chronic pruritus. This case study highlights the association between itch and malignancy and presents an atypical way of NET presentation when all tumor markers remain negative.

Keywords: itch; malignancy; neuroendocrine tumor(s); paraneoplastic; pruritus; tumor markers; urticaria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Erythematous papules, lesions with hematic crust located on the upper chest, lower and upper extremities.
Figure 2
Figure 2
Upper GI endoscopy. Gastroesophageal reflux changes are evident following the upper GI endoscopy GI, gastrointestinal.
Figure 3
Figure 3
Colonoscopy. Enlarged haustral folds are evident.
Figure 4
Figure 4
Skin biopsy results. (A) Hyperkeratosis with orthokeratosis described as thickening of the stratum corneum with parakeratosis seen as flattened keratinocyte nuclei within the stratum corneum and focal hypergranulosis observed as an increase in the intracellular granules of keratinocytes within the granular layer. H&E; magnification, x4. (B) Inflammatory cell infiltration around the blood vessels with few eosinophils and mast cell infiltrate (perivascular infiltration). H&E; magnification, x10. (C) Eosinophills. H&E; magnification, x20. (D) Few mast cells with metachromatic cytoplasm (presence of cytoplasmic granules characterizes mast cells). AT; magnification, x40.
Figure 5
Figure 5
(A-F) Abdominal CT scan showing a mass on the terminal ileum of the small bowel.
Figure 6
Figure 6
Histopathological images of NET G2 on anatomical specimen. (A and B) H&E; magnification, x5 and x10, respectively. (C) Synaptophysin; magnification, x5. (D) CDX2; magnification, x10).

References

    1. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 4th Edition, Volume 3, 2010.
    1. Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother. 2010;11:1673–1682. doi: 10.1517/14656566.2010.484420. - DOI - PMC - PubMed
    1. Pogatzki-Zahn E, Marziniak M, Schneider G, Luger TA, Stander S. Chronic pruritus: Targets, mechanisms and future therapies. Drug News Perspect. 2008;21:541–551. doi: 10.1358/dnp.2008.21.10.1314057. - DOI - PubMed
    1. Grundmann S, Ständer S. Chronic pruritus: Clinics and treatment. Ann Dermatol. 2011;23:1–11. doi: 10.5021/ad.2011.23.1.1. - DOI - PMC - PubMed
    1. Rajagopalan M, Saraswat A, Godse K, Shankar DS, Kandhari S, Shenoi SD, Tahiliani S, Zawar VV. Diagnosis and management of chronic pruritus: An expert consensus review. Indian J Dermatol. 2017;62:7–17. doi: 10.4103/0019-5154.198036. - DOI - PMC - PubMed

Publication types